Crinetics Pharmaceuticals/ US22663K1079 /
| 2024-05-17 9:59:51 PM | Chg. -0.52 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 51.37USD | -1.00% | 27,614 Turnover: 1.42 mill. |
-Bid Size: - | -Ask Size: - | 51.87 | 50.50 |
GlobeNewswire
05-10
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
05-09
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-08
Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Develop...
GlobeNewswire
05-02
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire
04-11
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(...
GlobeNewswire
03-19
Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase...
GlobeNewswire
03-12
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of ...
GlobeNewswire
03-11
Crinetics Pharmaceuticals Announces March 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4...
GlobeNewswire
02-28
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides C...
GlobeNewswire
02-28
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
GlobeNewswire
02-14
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February ...
GlobeNewswire
02-12
Crinetics Pharmaceuticals Announces February 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c...
GlobeNewswire
01-10
Crinetics Pharmaceuticals Announces January 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)...
GlobeNewswire
01-03
Crinetics Pharmaceuticals to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2023-12-18
Crinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine f...
GlobeNewswire
2023-12-11
Crinetics Pharmaceuticals Announces December 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c...
GlobeNewswire
2023-11-10
Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c...
GlobeNewswire
2023-11-07
Crinetics Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-10-10
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
2023-09-25
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Co...
GlobeNewswire
2023-09-20
Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023
GlobeNewswire
2023-09-13
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
GlobeNewswire
2023-09-11
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
GlobeNewswire
2023-09-11
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
